FOXP3 and non-small cell lung carcinoma: For instance, overexpressed Foxp3 in non-small cell lung cancer can act as a co-activator to facilitate the Wnt/β-catenin signaling pathway, leading to the induction of EMT and the stimulation of tumor growth and metastasis [70].